IRIS Accounts Production v26.2.0.496 13816867 Board of Directors 1.1.25 31.12.25 31.12.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh138168672024-12-31138168672025-12-31138168672025-01-012025-12-31138168672023-12-31138168672024-01-012024-12-31138168672024-12-3113816867ns15:EnglandWales2025-01-012025-12-3113816867ns14:PoundSterling2025-01-012025-12-3113816867ns10:Director12025-01-012025-12-3113816867ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3113816867ns10:SmallEntities2025-01-012025-12-3113816867ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3113816867ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3113816867ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3113816867ns10:FullAccounts2025-01-012025-12-311381686712025-01-012025-12-3113816867ns5:CurrentFinancialInstruments2025-12-3113816867ns5:CurrentFinancialInstruments2024-12-3113816867ns5:Non-currentFinancialInstruments2025-12-3113816867ns5:Non-currentFinancialInstruments2024-12-3113816867ns5:ShareCapital2025-12-3113816867ns5:ShareCapital2024-12-3113816867ns5:RetainedEarningsAccumulatedLosses2025-12-3113816867ns5:RetainedEarningsAccumulatedLosses2024-12-3113816867ns10:RegisteredOffice2025-01-012025-12-311381686712025-01-012025-12-3113816867ns5:NetGoodwill2025-01-012025-12-3113816867ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3113816867ns5:FurnitureFittings2025-01-012025-12-3113816867ns5:MotorVehicles2025-01-012025-12-3113816867ns5:NetGoodwill2024-12-3113816867ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3113816867ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-012025-12-3113816867ns5:NetGoodwill2025-12-3113816867ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-12-3113816867ns5:NetGoodwill2024-12-3113816867ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-3113816867ns5:LandBuildings2024-12-3113816867ns5:FurnitureFittings2024-12-3113816867ns5:MotorVehicles2024-12-3113816867ns5:LandBuildings2025-01-012025-12-3113816867ns5:LandBuildings2025-12-3113816867ns5:FurnitureFittings2025-12-3113816867ns5:MotorVehicles2025-12-3113816867ns5:LandBuildings2024-12-3113816867ns5:FurnitureFittings2024-12-3113816867ns5:MotorVehicles2024-12-3113816867ns5:AdditionsToInvestments2025-12-3113816867ns5:CostValuation2025-12-3113816867ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3113816867ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3113816867ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-12-3113816867ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-12-3113816867ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2025-12-3113816867ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2024-12-3113816867ns5:Secured2025-12-3113816867ns5:Secured2024-12-31
REGISTERED NUMBER: 13816867 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2025

for

TD Medicare Ltd

TD Medicare Ltd (Registered number: 13816867)

Contents of the Financial Statements
for the Year Ended 31 December 2025










Page

Balance Sheet 1

Notes to the Financial Statements 3


TD Medicare Ltd (Registered number: 13816867)

Balance Sheet
31 December 2025

31.12.25 31.12.24
Notes £ £
Fixed assets
Intangible assets 5 581,830 664,949
Tangible assets 6 183,244 15,783
Investments 7 955,203 -
1,720,277 680,732

Current assets
Stocks 26,547 33,902
Debtors 8 162,509 231,638
Cash at bank and in hand 70,279 97,527
259,335 363,067
Creditors
Amounts falling due within one year 9 (480,006 ) (381,768 )
Net current liabilities (220,671 ) (18,701 )
Total assets less current liabilities 1,499,606 662,031

Creditors
Amounts falling due after more than one year 10 (1,496,703 ) (626,987 )
Net assets 2,903 35,044

Capital and reserves
Called up share capital 100 100
Retained earnings 2,803 34,944
2,903 35,044

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

TD Medicare Ltd (Registered number: 13816867)

Balance Sheet - continued
31 December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 September 2026 and were signed on its behalf by:





Mr S Y Ting - Director


TD Medicare Ltd (Registered number: 13816867)

Notes to the Financial Statements
for the Year Ended 31 December 2025


1. Statutory information

TD Medicare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 13816867

Registered office: 21 Buxworth Close
Hull
Yorkshire
HU3 5DZ

The presentation currency of the financial statements is the Pound Sterling (£).


2. Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. Accounting policies

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Turnover
Turnover from shop sales is recognised at the point at which the goods are provided.

Income from the supply of prescriptions are recognised by reference to the items paid in the NHS monthly dispensing forms.

Where applicable, amounts are included net of value added tax, refunds and other sales discounts.

Goodwill
Goodwill on the acquisition of a business in 2022 is to be amortised over its estimated useful life of 10 years commencing on the first full year after acquisition.

Intangible assets
Other intangible assets have been written off in full in the year of acquisition.

TD Medicare Ltd (Registered number: 13816867)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025


3. Accounting policies - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Fixtures and fittings - 25% p.a. reducing balance
Motor vehicles - 25% p.a. reducing balance

Freehold property aquired in the year is held at cost as the directors believe that the residual value will be retained at this level.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and
slow moving items. Net realisable value is calculated at the lower of cost or selling price less cost to complete.

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.


TD Medicare Ltd (Registered number: 13816867)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025


3. Accounting policies - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Assets held under finance leases and hire purchase contracts are recognised in the balance sheet as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset.

Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. Employees and directors

The average number of employees during the year was 9 (2024 - 8 ) .

TD Medicare Ltd (Registered number: 13816867)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025


5. Intangible fixed assets
Other
intangible
Goodwill costs Totals
£ £ £
Cost
At 1 January 2025
and 31 December 2025 831,187 2 831,189
Amortisation
At 1 January 2025 166,238 2 166,240
Amortisation for year 83,119 - 83,119
At 31 December 2025 249,357 2 249,359
Net book value
At 31 December 2025 581,830 - 581,830
At 31 December 2024 664,949 - 664,949

6. Tangible fixed assets
Fixtures
Freehold and Motor
property fittings vehicles Totals
£ £ £ £
Cost
At 1 January 2025 - 2,376 23,000 25,376
Additions 181,742 - - 181,742
Disposals - - (23,000 ) (23,000 )
At 31 December 2025 181,742 2,376 - 184,118
Depreciation
At 1 January 2025 - 609 8,984 9,593
Charge for year - 265 - 265
Eliminated on disposal - - (8,984 ) (8,984 )
At 31 December 2025 - 874 - 874
Net book value
At 31 December 2025 181,742 1,502 - 183,244
At 31 December 2024 - 1,767 14,016 15,783

TD Medicare Ltd (Registered number: 13816867)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025


7. Fixed asset investments
Shares in
group
undertakings
£
Cost
Additions 955,203
At 31 December 2025 955,203
Net book value
At 31 December 2025 955,203

8. Debtors: amounts falling due within one year
31.12.25 31.12.24
£ £
Amounts owed by group undertakings 130,013 -
Other debtors - 210,013
VAT 27,998 21,530
Deferred tax asset 4,400 -
Prepayments 98 95
162,509 231,638

9. Creditors: amounts falling due within one year
31.12.25 31.12.24
£ £
Bank loans and overdrafts 142,283 37,210
Trade creditors 106,002 79,840
Corporation tax 10,486 39,869
Social security and other taxes 8,011 3,980
Other creditors 1,084 643
Directors' current accounts 157,100 197,100
Payments in advance 50,540 18,626
Accrued expenses 4,500 4,500
480,006 381,768

10. Creditors: amounts falling due after more than one year
31.12.25 31.12.24
£ £
Bank loans - 2-5 years 601,767 622,242
Bank loans more than 5 years by instalment 894,936 4,745
1,496,703 626,987

TD Medicare Ltd (Registered number: 13816867)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025


10. Creditors: amounts falling due after more than one year - continued
31.12.25 31.12.24
£ £
Amounts falling due in more than five years:

Repayable by instalments
Bank loans more than 5 years by instalment 894,936 4,745

11. Secured debts

The following secured debts are included within creditors:

31.12.25 31.12.24
£ £
Bank loans 1,638,986 664,197

Bank loans are secured by fixed charge over freehold property at 213 Ashby High Street, Scunthorpe and by an omnibus guarantee and set-off agreement between the Bank and the company and its subsidiary AAA Healthcare Limited together with such other security as the Bank may from time to time hold in respect of the debts and liabilities of any guarantor to the Bank.

An all monies guarantee from the directors for a principal amount of £498,000.

12. Directors' advances, credits and guarantees

The bank loans are secured by an all monies guarantee from the directors for a principal amount of £498,000.